Alzheimer's Detection AI

Patient Information

or drag and drop

Supported formats: PNG, JPG (max. 10MB)

Note: Only use T1 contrast mri scans

About Neurapex AI

At the intersection of artificial intelligence and medical innovation, Neurapex AI stands as a pioneering force in revolutionizing neurological and dermatological diagnostics. Our state-of-the-art platform harnesses the power of deep learning to provide unprecedented accuracy in early disease detection, transforming the landscape of preventive healthcare.

Our Vision & Mission

We envision a future where advanced AI technology makes early disease detection accessible to everyone, everywhere. Our mission is to revolutionize healthcare by providing medical professionals and institutions with cutting-edge diagnostic tools that enhance decision-making and improve patient outcomes through early intervention.

Advanced AI Technology Stack

Our platform leverages state-of-the-art artificial intelligence technologies, combining deep learning architecture with advanced medical imaging analysis:

  • Deep Learning CNN Architecture

    Custom-designed convolutional neural networks optimized for best possible accuracy on medical imaging analysis.

  • Advanced LLM Integration

    Powered by fine-tuned LLaMA 3.3 for comprehensive medical report generation

Comprehensive Alzheimer's Detection

Our advanced neural network specializes in analyzing T1-weighted MRI scans, providing detailed classification across multiple stages of Alzheimer's progression. The system has been trained on an extensive dataset of medical imaging, achieving 83% accuracy in clinical validation studies—outperforming many traditional diagnostic methods. This breakthrough technology represents a significant advancement in early Alzheimer's detection.

Classification Stages

No Alzheimer's Detected

No signs of Alzheimer's found.

Very Early Stage

Minor changes detected, possible early signs.

Early Stage

Signs of Alzheimer's—medical checkup recommended.

Middle Stage

Advanced signs—immediate medical care needed.

AI-Powered Analysis Process

  1. Advanced preprocessing of T1-weighted MRI scans
  2. Deep learning analysis using our proprietary CNN architecture
  3. Multi-stage classification with confidence scoring
  4. Comprehensive report generation using LLaMA 3.3
  5. Detailed medical insights and recommendations

Advanced Dermatological Analysis

Our dermatological AI system employs cutting-edge computer vision technology to analyze external skin conditions with exceptional precision. The platform is designed to detect and classify various skin conditions while maintaining the highest standards of accuracy and reliability.

Conditions Detected

  • Lichen Planus: Inflammatory condition
  • Melanoma: Skin cancer detection
  • Lichen Sclerosus: Chronic disorder
  • Lupus: Autoimmune manifestations
  • Healthy Skin: Normal classification

Key Features

  • High-resolution image analysis
  • Real-time processing capabilities
  • Multi-condition detection
  • Detailed severity assessment
  • Automated reporting system

Why Choose Neurapex AI?

Advanced AI Architecture

State-of-the-art CNN models trained on extensive medical datasets for superior accuracy

Comprehensive Reports

Detailed medical insights powered by LLaMA 3.3, providing actionable diagnostic information

Data Security

end-to-end encryption for complete data protection

Current Status & Future Vision

Current Status: Our platform is currently available as a research tool for academic institutions and healthcare research facilities. With an 83% accuracy rate for Alzheimer's detection, we've already demonstrated significant potential to transform early diagnostic capabilities.

The Bigger Vision: While our current research platform shows tremendous promise, we're developing an expanded system that will integrate additional biomarkers, support a wider range of neurological conditions, and incorporate real-time monitoring capabilities—creating a comprehensive neural health ecosystem.

The Founder

Hey, I’m Jaiwardhan Tyagi, the mind behind Neurapex. Built in Ghaziabad, Uttar Pradesh, Neurapex is all about researching and developing better early detection technologies. The goal is simple—using AI to catch things early and make a real difference. It’s a passion project driven by curiosity and a vision for smarter, more efficient solutions.

Investment & Funding Opportunities

Neurapex AI is actively seeking strategic partnerships and investment to accelerate our development roadmap. As a cutting-edge healthtech startup, we offer multiple paths for collaboration and investment:

The Ask

We're raising funding to train more accurate and robust models and expanding our tech for endless applications.

  • 1L rupees after clinical validation
  • 1L at 5% equity
  • Valuing the company at 20L

Grant Funding Partnerships

We actively pursue government and private foundation grants for cutting-edge medical AI research. Our grant portfolio includes:

  • NIH SBIR/STTR grants for medical innovation
  • NSF AI research initiative funding
  • Foundation grants for Alzheimer's research

Connect With Us

Investment Inquiries

Our investment team is ready to discuss partnership opportunities and provide detailed information about our technology roadmap and financial projections.

Email

neurapex.ai@gmail.com

Join the Future of Medical Diagnostics

Experience the power of AI-driven healthcare with Neurapex AI. Our platform offers unparalleled accuracy in disease detection, providing medical professionals with the tools they need for early intervention and improved patient outcomes.

Empowering healthcare through artificial intelligence—a specialist in your notebook